3-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 95%, 1g

1-(tert-Butoxycarbonyl)-4-(4-fluorobenzyl)piperidine-4-carboxylic acid, 97%, 100mg

6-Methyl-1,2,3,4-tetrahydroisoquinoline hydrochloride, 95.0%, 5g

4-(4-(2-Hydroxyethyl)piperazin-1-yl)butane-1-sulfonic acid, 95.0%, 5g

N,N,N-Trimethylethanaminium iodide, 98.0%, 5g

1-(3-Amino-2-methoxyphenyl)ethan-1-one, 98%, 250mg

5-(1,3-Dioxolan-2-yl)-2-(4-phenoxybenzoyl)thiophene, 97.0%, 1g

1,2,3,4,5,6,7,8-Octahydroacridine, 98%, 1g

3-(3-Bromo-4-fluorophenyl)propanoic acid, 97.0%, 5g

Colonna capillare per GC ROTI®Cap-1, 50 m, 0,25 mm, 0,50 µm, 1 Pezzo(i)

1-methyl-1H-imidazo[1,2-b]pyrazole-7-carboxylic acid, 95.0%, 10g

5,7-DICHLORO-1,2,3,4-TETRAHYDROISOQUINOLINE HYDROCHLORIDE, 95.0%, 250mg

2-(2-AMINOPHENYL)-4-METHYLPENTAN-2-OL, 95%, 1g